CD74 induces TAp63 expression leading to B-cell survival

Blood

Volumn 110, Issue 13, 2007, Pages 4303-4311

  Lantner, Frida ^a   Starlets, Diana ^a   Gore, Yael ^a   Flaishon, Liat ^a   Yamit Hezi, Ayala ^a   Dikstein, Rivka ^a   Leng, Lin ^b   Bucala, Richard ^b   Machluf, Yossy ^a   Oren, Moshe ^a   Shachar, Idit ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD74 ANTIGEN; CELL DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOCYTE ANTIGEN; PROTEIN BCL 2; PROTEIN P53; PROTEIN P63; UNCLASSIFIED DRUG; B LYMPHOCYTE ANTIGEN; HLA ANTIGEN CLASS 2; PHOSPHOPROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR RELA; TRP63 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; BCL 2 GENE; CELL CYCLE S PHASE; CELL SURVIVAL; CONTROLLED STUDY; DNA SYNTHESIS; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSACTIVATION; ACTIVE TRANSPORT; ANIMAL; B LYMPHOCYTE; BIOSYNTHESIS; CYTOLOGY; GENETIC TRANSCRIPTION; GENETICS; INVARIANT CHAIN; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; UPREGULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; B-LYMPHOCYTES; CELL SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; MICE, KNOCKOUT; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 39649113790     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-04-087486     Document Type: Article

References (33)

1. Stumptner-Cuvelette P, Benaroch P. Multiple roles of the invariant chain in MHC class II function. Biochim Biophys Acta. 2002;1542:1-13.
2. Naujokas MF, Morin M, Anderson MS, Peterson M, Miller J. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell. 1993;74:257-268.
3. Meyer-Siegler KL, Vera PL. Substance P induced changes in CD74 and CD44 in the rat bladder. J Urol. 2005;173:615-620.
4. Leng L, Metz CN, Fang Y, et al. MIF signal transduction initiated by binding to CD74. J Exp Med. 2003;197:1467-1476.
5. Shachar I, Flavell RA. Requirement for invariant chain in B cell maturation and function. Science. 1996;274:106-108.
6. Matza D, Wolstein O, Dikstein R, Shachar I. Invariant chain induces B cell maturation by activating TAFII105-NF-kB dependent transcription program. J Biol Chem. 2001;276:27203-27206.
7. Matza D, Kerem A, Lantner F, Shachar I. Invariant chain induced B cell differentiation requires intramembrane: proteolytic release of the cytosolic domain. Immunity. 2002;17:549-560.
8. Becker-Herman S, Arie G, Medvedovsky H, Kerem A, Shachar I. CD74 is a member of the regulated intramembrane proteolysis (RIP) processed protein family. Mol Biol Cell. 2005;16:5061-5069.
9. Matza D, Kerem A, Shachar I. Invariant chain, a chain of command. Trends Immunol. 2003;24:246-248.
10. Starlets D, Gore Y, Binsky I, et al. Cell surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood. 2006;107:4807-4816.
11. Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell. 1998;2:305-316.
12. Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 1999;398:714-718.
13. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature. 1999;398:708-713.
14. Elliott EA, Drake JR, Amigorena S, et al. The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J Exp Med. 1994;179:681-694.
15. Shachar I, Elliot EA, Chasnoff B, Grewal IS, Flavell RA. Reconstitution of invariant chain function in transgenic mice in vivo by individual p31 and p41 isoforsm. Immunity. 1995;3:373-383.
16. Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry. 1994;33:14144-14155.
17. Orlando V, Strutt H, Paro R. Analysis of chromatin structure by in vivo formaldehyde cross-linking. Methods. 1997;11:205-214.
18. Ortt K, Sinha S. Derivation of the consensus DNA-binding sequence for p63 reveals unique requirements that are distinct from p53. FEBS Lett. 2006;580:4544-4550.
19. Patke A, Mecklenbrauker I, Tarakhovsky A. Survival signaling in resting B cells. Curr Opin Immunol. 2004;16:251-255.
20. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol. 2002;2:725-734.
21. Schiemann B, Gommerman JL, Vora K, et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science. 2001;293:2111-2114.
22. Benlagha K, Park SH, Guinamard R, et al. Mechanisms governing B cell developmental defects in invariant chain-deficient mice. J Immunol. 2004;172:2076-2083.
23. Pellegrini G, Dellambra E, Golisano O, et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci U S A. 2001;98:3156-3161.
24. McKeon F. p63 and the epithelial stem cell: more than status quo? Genes Dev. 2004;18:465-469.
25. Nylander K, Vojtesek B, Nenutil R, et al. Differential expression of p63 isoforms in normal tissues and neoplastic cells. J Pathol. 2002;198:417-427.
26. Moll UM, Slade N. p63 and p73: roles in development and tumor formation. Mol Cancer Res. 2004;2:371-386.
27. Gressner O, Schilling T, Lorenz K, et al. TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J. 2005;24:2458-2471.
28. Jacobs WB, Govoni G, Ho D, et al. p63 is an essential proapoptotic protein during neural development. Neuron. 2005;48:743-756.
29. Wu G, Nomoto S, Hoque MO, et al. DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res. 2003;63:2351-2357.
30. Hibi K, Trink B, Patturajan M, et al. AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci U S A. 2000;97:5462-5467.
31. Hedvat CV, Teruya-Feldstein J, Puig P, et al. Expression of p63 in diffuse large B-cell lymphoma. Appl Immunohistochem Mol Morphol. 2005;13:237-242.
32. Park CK, Oh YH. Expression of p63 in reactive hyperplasias and malignant lymphomas. J Korean Med Sci. 2005;20:752-758.
33. Pruneri G, Fabris S, Dell'Orto P, et al. The transactivating isoforms of p63 are overexpressed in high-grade follicular lymphomas independent of the occurrence of p63 gene amplification. J Pathol. 2005;206:337-345.